WT1 peptide-loaded dendritic cell vaccine - Medinet

Drug Profile

WT1 peptide-loaded dendritic cell vaccine - Medinet

Alternative Names: Peptivator-pulsed dendritic cell vaccine - Medinet

Latest Information Update: 23 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Medinet
  • Class Cancer vaccines; Dendritic cell vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Solid tumours

Most Recent Events

  • 23 May 2016 Phase-II development is ongoing in Japan
  • 01 Dec 2014 Medinet completes a phase II trial in Solid Tumours in Japan (UMIN000009447)
  • 01 Dec 2012 Phase-II clinical trials in Solid tumours in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top